Non-ownership Filings
| Allergy Therapeutics presents findings at EAACI | Jun. 13, 2025 |
| EAACI Early Career Research Award | Jun. 10, 2025 |
| Interim Results for six months ended 31 Dec 2024 | Mar. 31, 2025 |
| Advancement to final phase of PROTECT trial | Mar. 27, 2025 |
| Presentations at 2025 AAAAI / WAO Joint Congress | Feb. 27, 2025 |
| Grass MATA MPL Phase III data published in Allergy | Feb. 17, 2025 |
| Half Year Trading update | Jan. 28, 2025 |
Ownership Update Filings
| New Executive Long Term Incentive Awards | Mar. 03, 2025 |
| Grant of Options | Feb. 14, 2025 |
| PDMR Dealing and Total Voting Rights | Jan. 22, 2025 |
| Director/PDMR Shareholding | Jan. 15, 2025 |
| Launch of new Company Long Term Incentive Plan | Jul. 04, 2024 |
| PDMR dealing and Total Voting Rights | Dec. 13, 2023 |
| Holding(s) in Company | Nov. 28, 2023 |